Cowen Financial Products LLC 13D and 13G filings for Jounce Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-02 12:28 pm Sale | 2023-12-29 | 13G | Jounce Therapeutics, Inc. JNCE | Cowen Financial Products LLC | 0 0.000% | -3,647,430 (Position Closed) | Filing |
| 2023-01-23 3:48 pm Purchase | 2022-12-30 | 13G | Jounce Therapeutics, Inc. JNCE | Cowen Financial Products LLC | 3,647,430 7.050% | 567,078 (+18.41%) | Filing |
| 2022-04-22 10:54 am Purchase | 2022-04-21 | 13G | Jounce Therapeutics, Inc. JNCE | Cowen Financial Products LLC | 3,080,352 5.960% | 3,080,352 (New Position) | Filing |